Breaks Categories: News

ThursdayMay 19, 2022 2:38 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Aims to Deliver Safer Alternative for Nicotine Experience

Lexaria Bioscience Corp. (NASDAQ: LEXX) will soon begin a human clinical study, NIC-H22-1, to compare its DehydraTECH-nicotine pouch performance with that of existing brands such as ON! and Zyn, currently available in the U.S. “Animal testing has already demonstrated that DehydraTECH-nicotine can deliver peak nicotine performance to the bloodstream 10 to 20 times faster than the study’s controls,” a recent article reads. “Lexaria has long held that any form of inhaling chemical substances can be detrimental to health, and its DehydraTECH-nicotine aims to help vapers as well as smokers wean themselves off of those products, giving them relief from cravings…

Continue Reading

WednesdayMay 18, 2022 11:34 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Upcoming Cannabis Landscape Webinar, Launches Highsman Helix

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, is hosting a webinar focused on the global cannabis regulatory landscape; the event is scheduled for Thursday, May 19, at 4 p.m. EDT. Titled “The State of the Play: Cannabis Regulatory Landscape,” the webinar will feature Flora Growth executives, including president and CEO Luis Merchan, COO Jason Warnock and newly appointed VP of regulatory affairs Holly Bell. The webinar agenda includes an overview of the opportunities and challenges facing Flora and other cannabis companies operating in the United States, Colombia and other global…

Continue Reading

WednesdayMay 18, 2022 11:21 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Status Update Regarding MCTO

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has shared a status update on the management cease trade order (“MCTO”) the company received from the British Columbia Securities Commission; the MCTO was effective on May 3, 2022, under the National Policy 12-203. In the update, the company references its original press release, which announced a delay in the filing of key financial statements and accompanying management’s discussion and analysis for FY 2021, a delay that would extend beyond the period outlined in the applicable Canadian securities laws. The update also noted…

Continue Reading

MondayMay 16, 2022 1:33 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Appointment of Cannabis Regulatory Veteran

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its appointment of regulatory veteran Holly Bell as vice president of regulatory affairs. According to the update, Bell will play a crucial role in Flora’s domestic and global expansion strategy and lead government relations in key international markets. “Holly’s unique knowledge and understanding of the United States’ regulatory framework will position us to make thoughtful, educated and bold decisions regarding strategic distribution, cultivation and sales plans,” said Luis Merchan, president and CEO of Flora Growth. “We look forward to bringing Holly’s expertise…

Continue Reading

FridayMay 13, 2022 12:04 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced financial results for the third quarter ended March 31, 2022. “The third quarter of fiscal 2022 saw noticeable advancements across all of our programs, including commencing sales of the rare cannabinoids CBDV and CBT as raw ingredients for the health and wellness industry,” said Eric A. Adams, InMed president and CEO. “For the remainder of fiscal 2022, we will remain focused on driving our commercial operations by expanding our product portfolio, increasing sales of our existing and new rare…

Continue Reading

ThursdayMay 12, 2022 11:41 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Establish Presence in the UK and EU

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced expansion of its operational footprint in Europe and the United Kingdom, furthering its international growth strategy. According to the update, the London-based offices will serve as the regional headquarters for Flora’s sales force and management of its distribution centers in the U.K. and Netherlands. Flora additionally bolsters its strategic positioning in the region by partnering with Hoshi to distribute the company’s broader product portfolio to 11 countries, including Germany, Portugal, the U.K., Italy, Poland, the Czech Republic, Denmark, the Netherlands, Switzerland, Malta,…

Continue Reading

WednesdayMay 11, 2022 2:05 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Launch of Vessel in Canada, OCS Partnership

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its Vessel brand, a leader in premium cannabis accessories, secured meaningful penetration in Canada via an approved listing on the Ontario Cannabis Store (“OCS”). In addition, Vessel has launched its Canadian direct-to-consumer online store, www.VesselBrand.ca, to service customers directly across the country. “We’re elated about our partnership with the OCS and are looking forward to bringing the full Vessel experience to our loyal customers across Canada,” said Flora’s Chief Strategy Officer James Choe. “Our internal estimates show the Canadian cannabis market…

Continue Reading

FridayMay 06, 2022 11:24 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and operating results for its fiscal year ended Dec. 31, 2021. During the webcast, Flora’s management will deliver comments on financial results, operational highlights from 2021, as well as share a brief look at the company’s performance in 2022 thus far. Following the presentation, analysts, media and investors will be afforded the opportunity to ask questions in a Q&A session. Interested parties may join the webcast…

Continue Reading

ThursdayMay 05, 2022 11:52 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite and weight/BMI. According to the update, BayMedia will be supplying its highly pure d-9 dominant THCV, formulated into a proprietary lozenge manufactured by Trokie. “We are excited to be part of this groundbreaking study with Trokie and Radicle Science in advance of our commercial launch…

Continue Reading

WednesdayMay 04, 2022 1:50 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Launches New Skincare Line Ahead of Luxury Meets Cannabis Conference

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the launch of a new skincare line under its brand, MIND Naturals (“Mind”), ahead of the Luxury Meets Cannabis Conference (“LMCC”) in New York City. Mind is inspired by its Colombian roots and leverages superfruits and nutrients native to Colombia for its new non-CBD line of skincare products. “This is a very exciting launch from MIND Naturals and Flora - the U.S. skincare market alone presents a unique opportunity for growing all-natural skincare brands, with annual revenue of approximately $17.6 billion,” said Flora…

Continue Reading